490 related articles for article (PubMed ID: 4935444)
21. The therapeutic uses of calcitonin.
Martin TJ
Scott Med J; 1978 Apr; 23(2):161-5. PubMed ID: 644299
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Delmas PD; Chapuy MC; Meunier PJ
Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Paget's disease with calcitonin.
DeRose J; Avramides A; Baker RK; Wallach S
Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
[No Abstract] [Full Text] [Related]
24. Biochemical markers of bone turnover in Paget's disease.
Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
[TBL] [Abstract][Full Text] [Related]
25. [Human calcitonin in the treatment of symptomatic Paget's disease].
Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
[TBL] [Abstract][Full Text] [Related]
26. Renal effects of calcitonin.
Cochran M; Peacock M; Sachs G; Nordin BE
Br Med J; 1970 Jan; 1(5689):135-7. PubMed ID: 5460839
[TBL] [Abstract][Full Text] [Related]
27. Salmon and porcine calcitonin treatment of Paget's disease of bone.
Avramides A
Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
[No Abstract] [Full Text] [Related]
28. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Drake S; Massie JD; Postlethwaite AE; Palmieri GM
Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
[TBL] [Abstract][Full Text] [Related]
29. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
30. [Biological exploration of Paget's disease].
Eisinger J; Laponche AM; Roux H; Recordier AM
Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):105-11. PubMed ID: 131366
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
Haddad JG; Caldwell JG
J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term porcine calcitonin administration in patients with Paget's disease or osteoporosis.
Veer JV; Bijvoet OL; Smeenk D
Calcif Tissue Res; 1970; ():Suppl:88. PubMed ID: 5464079
[No Abstract] [Full Text] [Related]
33. Newer agents in treating Paget's disease of bone.
Goldfield EB
Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
[No Abstract] [Full Text] [Related]
34. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
35. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
Deplante JP; Daumont A; Bouvier M; Lejeune E
Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
Kuhlencordt F; Ringe JD; Kruse HP
Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
[TBL] [Abstract][Full Text] [Related]
37. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
Condon JR; Surtees J; Robinson V
Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
[TBL] [Abstract][Full Text] [Related]
38. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
[No Abstract] [Full Text] [Related]
39. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
[TBL] [Abstract][Full Text] [Related]
40. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study.
Pontiroli AE; Pajetta E; Calderara A; Alberetto M; Pozza G; Manganelli V; Resmini G; Tessari L; Maresca V
J Endocrinol Invest; 1991 Jan; 14(1):47-51. PubMed ID: 1646250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
